Myriad Genetics (MYGN) Goodwill (2011 - 2026)

Myriad Genetics (MYGN) has 16 years of Goodwill data on file, last reported at $47.1 million in Q1 2026.

• Goodwill for Q1 2026 came in at $47.1 million, down 83.55% year-over-year; the trailing twelve-month figure through Mar 2026 was $47.1 million (down 83.55% YoY), and the FY2025 annual result was $51.6 million, down 81.98% from the prior year.
• Goodwill eased to $47.1 million in Q1 2026 per MYGN's latest filing, from $51.6 million in the prior quarter.
• Over five years, Goodwill peaked at $287.4 million in Q4 2023 and troughed at $47.1 million in Q1 2026.
• A 5-year average of $222.5 million and a median of $286.3 million in 2024 frame the typical range for Goodwill.
• The sharpest annual moves came in 2023 and 2026: Goodwill climbed 21.18% in 2023, then plunged 83.55% in 2026.
• A 5-year view of Goodwill shows it stood at $286.8 million in 2022, then grew by 0.21% to $287.4 million in 2023, then dropped by 0.38% to $286.3 million in 2024, then plunged by 81.98% to $51.6 million in 2025, then slipped by 8.72% to $47.1 million in 2026.
• Business Quant data shows MYGN's Goodwill at $47.1 million in Q1 2026, $51.6 million in Q4 2025, and $51.6 million in Q3 2025.